Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |